Document is current
Any future updates will be listed below
-
Authors
Yang, Tao
Tran, Kevin C.
Zeng, Anne Y.
Massa, Stephen M.
Longo, Frank M.
-
Funding
Funding for this research was provided by:
Horngren Family Alzheimer's Research Fund
Jean Perkins Foundation
General Alzheimer's Research Donor Fund
Buena Thomas AD Research Fund
- License Information
-
More Information
Article History
Received: 7 April 2020
Accepted: 29 October 2020
First Online: 23 November 2020
Competing interests
: FML and SMM are listed as inventors on patents relating to a compound in this report that is assigned to the University of North Carolina, University of California, San Francisco and the Dept. of Veterans Affairs. SMM and FML are entitled to royalties distributed by UC and the VA per their standard agreements. FML is a principal of, and has financial interest in PharmatrophiX, a company focused on the development of small molecule ligands for neurotrophin receptors that has licensed several of these patents. TY, KCT and AYZ declare no competing interests.
